Advanced Devices for Injectable Drugs

Posted: Published on January 23rd, 2013

This post was added by Dr P. Richardson

NEW YORK, Jan. 23, 2013 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Advanced Devices for Injectable Drugs

http://www.reportlinker.com/p01085205/Advanced-Devices-for-Injectable-Drugs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as specialty syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines injection devices engineered with features that advance the state-of-the-art for injectable drugs, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injection devices on the competitive landscape

Analyzes advanced syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

Provides detailed descriptions advanced devices for injectable drugs and assesses the impact of advanced features on therapeutic segments

Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Executive Summary

Read more from the original source:
Advanced Devices for Injectable Drugs

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.